Charlotte Wagner was tired of getting winded while walking a few steps.

She hated the stares from patrons around her when she couldn't fit in an auditorium seat at Belleville East High School.

"I had to bring my own chair or I couldn't go," said Charlotte, 48, who has lost 140 pounds since having gastric bypass surgery in August 2007 at St. Alexius Hospital in St. Louis.

Alison Davies' eyes sparkled with excitement as she discussed her future, hardly looking like she had undergone surgery less than 24 hours ago.

"It's like a rebirth," Davies said of the laparoscopic mini-gastric bypass surgery that she said changed her life forever.

 

Cambridge Endo, a pioneer in the rapidly emerging LESS (also called Single Port Access Laparoscopic Surgery or SPA) market, is pleased to announce that its president and founder, Woojin Lee, was among the industry leaders selected to be on a LESS panel at the Cleveland Clinic Medical Innovation Summit. Cambridge Endo developed, manufactures and markets the innovative Autonomy(TM) Laparo-Angle(TM) articulating instruments which, it believes, is the enabling technology that will drive the rapid uptake of this major advance in laparoscopic  surgery.

"It’s my psychic income,? says Dr. Susan Downey of the lip and palate surgery she has performed on hundreds of children worldwide.

Downey recently returned from her 14th international trip to improve the lives of others through plastic surgery. The trip to Cuenca in Ecuador in November was her first with Women for World Health. “It was an all-women team composed of myself and another surgeon, nurses, anesthesiologists, a pediatrician and coordinators.
“Our hosts were the Rotary Club of Cuenca, and they were wonderful.?

According to the Centers for Disease Control (CDC), during the past 20 years there has been a dramatic increase in obesity in the United States, with more than one-third of the population considered obese.  "This is a major health concern because obesity increases the risks of many diseases and health conditions such as high blood pressure, high cholesterol, diabetes, stroke and bone degeneration."

Like traditional conference rooms, the giant TV screen on the wall at Jennifer Baran’s company in Clarence is situated so attendees can easily see the presentation.

But unlike traditional conference rooms, hers is void of a long table ringed with chairs.

Among insured patients newly prescribed second-generation antipsychotics, monitoring of blood glucose and lipid levels falls far short of 2004 American Diabetes Association (ADA) guidelines, researchers report [1].

The guidelines are based on substantial evidence that these drugs can increase risk for cardiovascular disease by affecting lipid and glucose metabolism and body weight.

On Thursday, July 17th, fat people in our nation began to rejoice at the breaking news. After years of conflicting advice detailing the best approach to dealing with weight loss, finally, the medical community had spoken. The obesity epidemic should be about to come to a screaming halt because one of the most prestigious medical journals presented its astounding findings. The New England Journal of Medicine published findings of a diet study promoting the weight loss benefits of adhering to a low carb diet.

Every day, we here at News 12 tell your stories, but now, we have our own story to share. We know it's getting harder and harder for you to keep your New Year's resolution of losing weight and getting in shape. In fact, now is the time a lot of people give up, but two people in our building will probably inspire you to hang on.

Every morning, you wake up with News 12's Stacey Hilton and Meteorologist Tim Strong, but you are also starting your morning with someone you can't see: Chazaray Robinson.
We know him as "Chaz," our morning director.

GASTRIC surgery is a last resort for people who are dangerously obese. But there may soon be a gentler option in the shape of a removable device inserted into the gut though the mouth.

The EndoBarrier, developed by GI Dynamics of Lexington, Massachusetts, is an impermeable sleeve that lines the first 60 centimetres of the small intestine. In animal experiments and preliminary human trials, it reduces weight and rapidly brings type II diabetes under control.